Cutaneous melanoma: Clinical, epidemiological and histopathological characteristics at the University Hospital of Brasília between January 1994 and April 1999;Melanoma ycutâneo: Características clínicas, epidemiológicas e histopatológicas no Hospital Universitário de Brasília entre Janeiro de 1994 e Abril de 1999

Anais Brasileiros de Dermatologia

Volumn 78, Issue 2, 2003, Pages 179-186

  Costa Pinheiro, Ana Maria ^a   Friedman, Horácio ^a   Santos Veiga Cabral, Andrea Leão ^a   Abe Rodrigues, Helbert ^a  

^a NONE

Author keywords

Epidemiology; Melanoma

Indexed keywords

ADULT; AGED; ARTICLE; BRAZIL; CANCER INCIDENCE; CAUCASIAN; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIMB; MALE; MELANOMA; TUMOR LOCALIZATION; UNIVERSITY HOSPITAL;

EID: 0043238972     PISSN: 03650596     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0365-05962003000200005     Document Type: Article

References (15)

1. Urist M.M. and Karnell L.H.. The national cancer data base Report on melanoma. Cancer, 1994; 74(2): 782-8.
2. Hall H.I., Miller D.R., Rogers J.D. and Bewerse B.. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol, 1999; 40(1):
3. MacKie R., Hunter J.A.A., Aitchison T.C., Hole D., et al.. Cutaneous malignant melanoma, Scotland, 1979-89. Lancet, 1992; 339: 971-75.
4. O'Doherty C.J., Prescott R.J., White H., McIntyre M. and Hunter J.A.A.. Sex differences in presentation of cutaneous malignant melanoma and survival from stage I disease. Cancer, 1986; 58: 788-92.
5. Levi F., La Vecchia C., Van-Cong T. and Mezzanotte G.. Descriptive epidemiology of skin cancer in the Swiss Canton of Vaud. Int J Cancer, 1988; 42: 811-16.
6. Mansson-Brahme E., Carstensen J., Erhardt K., Lagerlöf B., Ringborg U. and Rutqvist L.E.. Prognostic factors in thin cutaneous malignant melanoma. Cancer, 1994; 73(9): 2324-31.
7. Thune I., Olsen A., Albrektsen G. and Tretli S.. Cutaneous malignant melanoma: Association with height, weight and body-surface area. A prospective study in Norway. Int J Cancer, 1993; 55: 555-61.
8. Levi F., Randimbison L., La Vecchia C., Van-Cong T. and Franceschi S.. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland. Int J Cancer, 1998; 78: 315-19.
9. Criado P.R., Vasconcellos C., Sittart J.A.S., Valente N.Y.S., et al.. Melanoma maligno cutânco primário: estudo retrospectivo de 1963 a 1997 no Hospital do Servidor Público Estadual de São Paulo. Rev Ass Med Brasil, 1999; 45: 157-62.
10. Lang P.G. Jr.. Malignant melanoma. Med Clin North Am, 1998; 82(6): 1325-58.
11. Reed J.a, Albino A.P.. Update of diagnostic and prognostic markers in cutaneous malignant melanoma. Dermatol Clin, 1999; 17(3): 631-43.
12. Stadelmann W.K., Reintgen D.S.. Prognosis in malignant melanoma. Hematol Oncol Clin North Am, 1998; 12(4): 767-96.
13. Benvegnú L.A., Pasqualotto A.C., Santos R.P. and Copette F.R.. Melanoma cutâneo na região central do Rio Grande do Sul: análise de 79 casos. Rev AMRIGS, 1997; 41: 208-12.
14. MacLennan R., Green A.C., McLeod G.R.C. et al.. Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst, 1992; 84: 1427-32.
15. Cohn-Dedermark G., Mansson-Brahme E., Rutqvist L.E., et al.. Trends in mortality from malignant melanoma in Sweden, 1970-1996. Cancer, 2000; 89(2): 348-55.